This trial has been terminated.

Condition liver transplantation
Treatment ecom ett
Sponsor Mayo Clinic
Collaborator ConMed Corporation
Start date February 2011
End date December 2013
Trial size 40 participants
Trial identifier NCT01299441, 10-007600


The purpose of this study is to determine whether the endotracheal cardiac output monitor (ECOM) is accurate and predictive in liver failure patients with hyperdynamic circulatory changes.

United States No locations recruiting
Other countries No locations recruiting

Study Design

Observational model case-only
Time perspective prospective
Patients undergoing liver transplantation and intubated with ECOM endotracheal tube (ETT).
ecom ett
Intubation with ECOM endotracheal tube (ETT)

Primary Outcomes

endotracheal cardiac output monitor (ECOM), a non-invasive cardiac output monitor, is accurate and predictive
time frame: Less than 24 hours

Eligibility Criteria

All participants from 18 years up to 99 years old.

Inclusion Criteria: - Patients undergoing liver transplantation surgery Exclusion Criteria: - Patients who are anticipated to remain intubated postoperatively for greater than 24 hours.

Additional Information

Official title Noninvasive ECOM Monitoring of Hemodynamic Parameters During Liver Transplantation
Principal investigator Timothy Shine, MD
Trial information was received from ClinicalTrials.gov and was last updated in March 2017.
Information provided to ClinicalTrials.gov by Mayo Clinic.